Takayuki Akiyama

Dr. Takayuki Akiyama

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
KSKensuke Shoji
Kensuke Shoji
TATakayuki Akiyama
Takayuki Akiyama
STShinya Tsuzuki
Shinya Tsuzuki
NMNobuaki Matsunaga
Nobuaki Matsunaga
YAYusuke Asai
Yusuke Asai
NONorio Ohmagari
Norio Ohmagari

1 October 2015
Verified
Conference Paper
Closed access
PNPhong Nguyen
Phong Nguyen
TATakayuki Akiyama
Takayuki Akiyama
HOHiroki Ohashi
Hiroki Ohashi
GNGoh Nakahara
Goh Nakahara
KYKatsuya Yamasaki
Katsuya Yamasaki
SHSaito Hikaru
Saito Hikaru
For accurate indoor positioning, a moving activity recognition (AR) method has been developed that is based on a smartphone's sensor data. Prior methods can only recognize moving activities if the smartphone is held in a predefined place. We propose a method that works in various holding places to increase the usability. An SVM classifier is chosen because of its strength in utilizing features. New features are added such as percentiles of acceleration, air pressure, and acceleration magnitude. We have achieved 94.3% overall accuracy in various holding places: in users' hands, belt pouches, pant back pockets, and pant side pockets.

11 September 2022 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
KSKensuke Shoji
Kensuke Shoji
STShinya Tsuzuki
Shinya Tsuzuki
TATakayuki Akiyama
Takayuki Akiyama
NMNobuaki Matsunaga
Nobuaki Matsunaga
YAYusuke Asai
Yusuke Asai
NONorio Ohmagari
Norio Ohmagari

12 June 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
KSKensuke Shoji
Kensuke Shoji
YAYusuke Asai
Yusuke Asai
TATakayuki Akiyama
Takayuki Akiyama
STShinya Tsuzuki
Shinya Tsuzuki
NMNobuaki Matsunaga
Nobuaki Matsunaga
NONorio Ohmagari
Norio Ohmagari

14 September 2022 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
AEAkira Endo
Akira Endo
YAYusuke Asai
Yusuke Asai
TTTaichi Tajima
Taichi Tajima
MEMio Endo
Mio Endo
TATakayuki Akiyama
Takayuki Akiyama
NONorio Ohmagari
Norio Ohmagari

5 August 2022 in Infectious Disease Modelling
Verified
Journal Article
Open access
NMNobuaki Matsunaga
Nobuaki Matsunaga
KKKeisuke Kamata
Keisuke Kamata
YAYusuke Asai
Yusuke Asai
STShinya Tsuzuki
Shinya Tsuzuki
YSYasuaki Sakamoto
Yasuaki Sakamoto
NONorio Ohmagari
Norio Ohmagari
With the rapid increase in the number of COVID-19 patients in Japan, the number of patients receiving oxygen at home has also increased rapidly, and some of these patients have died. An efficient approach to identify high-risk patients with slowly progressing and rapidly worsening COVID-19, and to avoid missing the timing of therapeutic intervention will improve patient prognosis and prevent medical complications. Patients admitted to medical institutions in Japan from November 14, 2020 to April 11, 2021 and registered in the COVID-19 Registry Japan were included. Risk factors for patients with High Flow Nasal Cannula invasive respiratory management or higher were comprehensively explored using machine learning. Age-specific cohorts were created, and severity prediction was performed for the patient surge period. We were able to obtain a model that was able to predict severe disease with a sensitivity of 57% when the specificity was set at 90% for those aged 40–59 years, and with a specificity of 50% and 43% when the sensitivity was set at 90% for those aged 60–79 years and 80 years and older, respectively. We were able to identify lactate dehydrogenase level (LDH) as an important factor in predicting the severity of illness in all age groups. Using machine learning, we were able to identify risk factors with high accuracy, and predict the severity of the disease. We plan to develop a tool that will be useful in determining the indications for hospitalisation for patients undergoing home care and early hospitalisation.